Logo image of MBCN

MIDDLEFIELD BANC CORP (MBCN) Stock Fundamental Analysis

NASDAQ:MBCN - Nasdaq - US5963042040 - Common Stock - Currency: USD

29.3  +0.35 (+1.21%)

After market: 29.3 0 (0%)

Fundamental Rating

4

Taking everything into account, MBCN scores 4 out of 10 in our fundamental rating. MBCN was compared to 395 industry peers in the Banks industry. MBCN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MBCN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MBCN had positive earnings in the past year.
In the past year MBCN had a positive cash flow from operations.
In the past 5 years MBCN has always been profitable.
MBCN had a positive operating cash flow in each of the past 5 years.
MBCN Yearly Net Income VS EBIT VS OCF VS FCFMBCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

MBCN's Return On Assets of 0.86% is in line compared to the rest of the industry. MBCN outperforms 52.41% of its industry peers.
MBCN has a Return On Equity (7.57%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.86%
ROE 7.57%
ROIC N/A
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
MBCN Yearly ROA, ROE, ROICMBCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 23.39%, MBCN perfoms like the industry average, outperforming 49.11% of the companies in the same industry.
In the last couple of years the Profit Margin of MBCN has declined.
The Operating Margin and Gross Margin are not available for MBCN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.39%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MBCN Yearly Profit, Operating, Gross MarginsMBCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

MBCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
MBCN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MBCN has more shares outstanding
The debt/assets ratio for MBCN has been reduced compared to a year ago.
MBCN Yearly Shares OutstandingMBCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MBCN Yearly Total Debt VS Total AssetsMBCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of MBCN is 0.61, which is an excellent value as it means it would take MBCN, only 0.61 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.61, MBCN belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that MBCN is not too dependend on debt financing.
MBCN's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. MBCN outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.61
Altman-Z N/A
ROIC/WACCN/A
WACC14.65%
MBCN Yearly LT Debt VS Equity VS FCFMBCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBCN Yearly Current Assets VS Current LiabilitesMBCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.45% over the past year.
MBCN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.06% yearly.
MBCN shows a decrease in Revenue. In the last year, the revenue decreased by -1.85%.
The Revenue has been growing slightly by 7.99% on average over the past years.
EPS 1Y (TTM)5.45%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%17.65%
Revenue 1Y (TTM)-1.85%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%7.62%

3.2 Future

Based on estimates for the next years, MBCN will show a small growth in Earnings Per Share. The EPS will grow by 4.67% on average per year.
Based on estimates for the next years, MBCN will show a small growth in Revenue. The Revenue will grow by 6.83% on average per year.
EPS Next Y11.13%
EPS Next 2Y4.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y6.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MBCN Yearly Revenue VS EstimatesMBCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MBCN Yearly EPS VS EstimatesMBCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

MBCN is valuated correctly with a Price/Earnings ratio of 13.76.
Compared to the rest of the industry, the Price/Earnings ratio of MBCN indicates a slightly more expensive valuation: MBCN is more expensive than 64.81% of the companies listed in the same industry.
MBCN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.11 indicates a correct valuation of MBCN.
71.14% of the companies in the same industry are cheaper than MBCN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of MBCN to the average of the S&P500 Index (22.19), we can say MBCN is valued slightly cheaper.
Industry RankSector Rank
PE 13.76
Fwd PE 13.11
MBCN Price Earnings VS Forward Price EarningsMBCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBCN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.4
EV/EBITDA N/A
MBCN Per share dataMBCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.24
PEG (5Y)12.95
EPS Next 2Y4.67%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

MBCN has a Yearly Dividend Yield of 2.85%.
MBCN's Dividend Yield is comparable with the industry average which is at 3.46.
MBCN's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.85%

5.2 History

The dividend of MBCN is nicely growing with an annual growth rate of 6.90%!
MBCN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.9%
Div Incr Years0
Div Non Decr Years0
MBCN Yearly Dividends per shareMBCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

40.42% of the earnings are spent on dividend by MBCN. This is a bit on the high side, but may be sustainable.
MBCN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.42%
EPS Next 2Y4.67%
EPS Next 3YN/A
MBCN Yearly Income VS Free CF VS DividendMBCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MBCN Dividend Payout.MBCN Dividend Payout, showing the Payout Ratio.MBCN Dividend Payout.PayoutRetained Earnings

MIDDLEFIELD BANC CORP

NASDAQ:MBCN (6/18/2025, 8:05:10 PM)

After market: 29.3 0 (0%)

29.3

+0.35 (+1.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-16 2025-07-16/bmo
Inst Owners26.86%
Inst Owner Change0.07%
Ins Owners3.31%
Ins Owner Change0.81%
Market Cap236.74M
Analysts48.89
Price Target28.9 (-1.37%)
Short Float %0.72%
Short Ratio6.11
Dividend
Industry RankSector Rank
Dividend Yield 2.85%
Yearly Dividend0.8
Dividend Growth(5Y)6.9%
DP40.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.26%
Min EPS beat(2)27.95%
Max EPS beat(2)28.58%
EPS beat(4)3
Avg EPS beat(4)18.02%
Min EPS beat(4)-11.17%
Max EPS beat(4)28.58%
EPS beat(8)4
Avg EPS beat(8)7.18%
EPS beat(12)8
Avg EPS beat(12)8.13%
EPS beat(16)12
Avg EPS beat(16)9.84%
Revenue beat(2)1
Avg Revenue beat(2)1.3%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)2.64%
Revenue beat(4)1
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)2.64%
Revenue beat(8)2
Avg Revenue beat(8)-1.73%
Revenue beat(12)3
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-1.34%
PT rev (1m)0%
PT rev (3m)2.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.66%
EPS NY rev (1m)0%
EPS NY rev (3m)14.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.55%
Valuation
Industry RankSector Rank
PE 13.76
Fwd PE 13.11
P/S 3.42
P/FCF 12.4
P/OCF 11.81
P/B 1.11
P/tB 1.38
EV/EBITDA N/A
EPS(TTM)2.13
EY7.27%
EPS(NY)2.23
Fwd EY7.63%
FCF(TTM)2.36
FCFY8.06%
OCF(TTM)2.48
OCFY8.47%
SpS8.56
BVpS26.46
TBVpS21.3
PEG (NY)1.24
PEG (5Y)12.95
Profitability
Industry RankSector Rank
ROA 0.86%
ROE 7.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.39%
GM N/A
FCFM 27.6%
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.61
Debt/EBITDA N/A
Cap/Depr 74.19%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 117.97%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC14.65%
ROIC/WACCN/A
Cap/Depr(3y)67.12%
Cap/Depr(5y)54.69%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.5%
Profit Quality(3y)113.84%
Profit Quality(5y)117.74%
High Growth Momentum
Growth
EPS 1Y (TTM)5.45%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%17.65%
EPS Next Y11.13%
EPS Next 2Y4.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.85%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%7.62%
Revenue Next Year8.67%
Revenue Next 2Y6.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.25%
FCF growth 3Y4.07%
FCF growth 5Y7.62%
OCF growth 1Y-10.26%
OCF growth 3Y4.24%
OCF growth 5Y5.35%